Extavia New MS Med

Links shared publicly online about this topic

US FDA Approves Extavia(R) - The First In A New Portfolio Of Planned MS Therapies From Novartis To Help Patients With This Devastating Disease

medicalnewstoday.com — “The US Food and Drug Administration (FDA) has approved Extavia(R) (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients manView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on August 18, 2009 at 12:56 pm By:

LisaEmrich Lisa Emrich Patient Expert

MedNewsToday: US FDA Approves Extavia(R) - The First In A New Portfolio Of Planned MS Therapies Fro.. http://bit.ly/MMOBo

3 years ago...

Novartis launches Extavia, a new therapeutic option to help patients combat devastating symptoms of multiple sclerosis

novartis.com — “Basel, January 22, 2009 - Novartis has today announced the launch of Extavia, a new version of the standard-of-care for relapsing forms of multiple sclerosis (MS), providing patients and physicians with an alternative option to help manage this devastating disease.View full resource at novartis.com

  • View Related
  • Share

Most Recently Shared on January 22, 2009 at 12:25 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

Novartis launches Extavia®, a new therapeutic option for patients with multiple sclerosis - http://is.gd/gOML

3 years ago...

US FDA approves Extavia - the first in a new portfolio of planned MS therapies from Novartis to help patients with this devastating disease

novartis.com — “Basel, August 17, 2009 - The US Food and Drug Administration (FDA) has approved Extavia (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients manage this devastating disease.View full resource at novartis.com

  • View Related
  • Share

Most Recently Shared on August 20, 2009 at 1:30 pm By:

eyeonfda eyeonfda Pharma and Health Lawyer

FDA approves Novartis' Extavia® for treatment of MS - http://bit.ly/sM6J3

3 years ago...

New Method Isolates Best Brain Stem Cells To Treat MS

medicalnewstoday.com — “The prospect of doing human clinical trials with stem cells to treat diseases like multiple sclerosis may be growing closer, say scientists at the University at Buffalo and the University at RocheView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on October 14, 2011 at 8:05 am By:

mnt_stemcell MNT Stem Cell News Health News

New Method Isolates Best Brain Stem Cells To Treat MS http://t.co/pa5RcHan #stemcell

7 months ago...

Pregnancy Safe for Most Women With MS: Study - Drugs.com MedNews

drugs.com — “Pregnancy is generally safe for women with multiple sclerosis, a new study says. Canadian researchers analyzed 432 births to women with MS and almost 3,000 birtView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on June 27, 2011 at 2:11 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Pregnancy Safe for Most Women With MS: Study: MONDAY, June 27 -- Pregnancy is generally safe for women wit... http://bit.ly/mSCZNA #drug

11 months ago...

Link Found Between Environment And Genetics In Triggering MS: Discovery Points To New, Personalized Treatments

medicalnewstoday.com — “Environmental and inherited risk factors associated with multiple sclerosis - previously poorly understood and not known to be connected - converge to alter a critical cellular function linked toView full resource at medicalnewstoday.com

  • View Related
  • Share

Most Recently Shared on June 1, 2011 at 8:05 am By:

LisaEmrich Lisa Emrich Patient Expert

MedNewsToday: Link Found Between Environment And Genetics In Triggering MS: Discovery Points To New, Personalize... http://bit.ly/lOVQav

12 months ago...

Medical News: MS Link to Venous Insufficiency Still Unclear, Debated - in Clinical Context, Multiple Sclerosis from MedPage Today

medpagetoday.com — “New findings from a meta-analysis may fuel the controversy over the link between chronic cerebrospinal venous insufficiency (CCSVI) and multiple sclerosis, researchers said.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on October 5, 2011 at 3:01 pm By:

Novel MS Pill Passes Early Test - QualityPoint Technologies

qualitypointtech.net — “NEW ORLEANS (MedPage Today) -- An investigational oral drug for multiple sclerosis markedly reduced the number of brain lesions relative to placebo in a phase II study, researchers will report here next week.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on April 17, 2012 at 6:45 pm By:

MedicalFeed MedicalFeed Health News Feed

Novel MS Pill Passes Early Test: NEW ORLEANS (MedPage Today) -- An investigational oral drug for multiple sclerosi... http://t.co/bIqZi5VL

1 month ago...

New Oral Drugs Hailed for Treating MS - Drugs.com MedNews

drugs.com — “For decades, research into treatments for multiple sclerosis has plodded forward, making slow but significant gains in improving the lives of people with the deView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on January 31, 2011 at 3:03 pm By:

Drugs_Devices Drugs and Devices OW OW Health

New Oral Drugs Hailed for Treating MS: MONDAY, Jan. 31 -- For decades, research into treatments for multip... http://bit.ly/dIdbhM #drug

1 year ago...

New Pill for MS Shows Promise in Clinical Trial - Drugs.com MedNews

drugs.com — “A new oral medication for the treatment of multiple sclerosis (MS) shows promise in slowing disease progression, limiting brain atrophy and reducing MS relapsesView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on April 13, 2011 at 2:36 am By:

Medical News: FDA Approves New Brand of Old MS Drug - in Product Alert, Prescriptions from MedPage Today

medpagetoday.com — “WASHINGTON -- The FDA approved a new brand of the multiple sclerosis drug interferon beta-1b, giving Novartis the green light to market the drug as Extavia.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on August 17, 2009 at 9:41 pm By:

Teva to Present New Data on Copaxone and Laquinimod at the 26th Annual ECTRIMS Congress - Drugs.com MedNews

drugs.com — “Studies Showcase Teva s Ongoing Commitment to Multiple Sclerosis Research Oct 6, 2010 - Teva Pharmaceutical Industries Ltd. (NASDAQ TEVA) announced today that mView full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on October 7, 2010 at 5:11 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Teva to Present New Data on Copaxone and Laquinimod at the 26th Annual ECTRIMS Congress: Studies Showcase Tev... http://bit.ly/cMJnjX #drug

2 years ago...

MS-Like Disease Found in Monkeys (CME/CE) - QualityPoint Technologies

qualitypointtech.net — “(MedPage Today) -- A potential new experimental model for multiple sclerosis, as well as support for a viral origin of the disease, appears to have emerged spontaneously among macaque monkeys in a research colony.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on July 1, 2011 at 5:45 pm By:

MedicalFeed MedicalFeed Health News Feed

MS-Like Disease Found in Monkeys (CME/CE): (MedPage Today) -- A potential new experimental model for multiple scle... http://bit.ly/ifiw6t

11 months ago...

Honing in on the Genetics of MS - Drugs.com MedNews

drugs.com — “A new study on the genetic underpinnings of multiple sclerosis (MS) has identified more than 50 gene variants that may contribute to the autoimmune disease, 29View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 10, 2011 at 7:14 pm By:

Drugs_Devices Drugs and Devices OW OW Health

Honing in on the Genetics of MS: WEDNESDAY, Aug. 10 -- A new study on the genetic underpinnings of multipl... http://bit.ly/nXhgJQ #drug

10 months ago...

Medical News: AAN Backs Plasma Exchange for MS - in Neurology, Multiple Sclerosis from MedPage Today

medpagetoday.com — “In a practice guideline released Monday, the American Academy of Neurology formally endorsed plasma exchange for treatment for severe exacerbations in relapsing-remitting multiple sclerosis (RR-MS), aView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on January 17, 2011 at 9:29 pm By:

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390